These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 16442285)

  • 21. Novel heteroaromatic organofluorine inhibitors of fructose-1,6-bisphosphatase.
    Rudnitskaya A; Huynh K; Török B; Stieglitz K
    J Med Chem; 2009 Feb; 52(3):878-82. PubMed ID: 19143528
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Allosteric FBPase inhibitors gain 10(5) times in potency when simultaneously binding two neighboring AMP sites.
    Hebeisen P; Kuhn B; Kohler P; Gubler M; Huber W; Kitas E; Schott B; Benz J; Joseph C; Ruf A
    Bioorg Med Chem Lett; 2008 Aug; 18(16):4708-12. PubMed ID: 18650089
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A library of novel allosteric inhibitors against fructose 1,6-bisphosphatase.
    Heng S; Gryncel KR; Kantrowitz ER
    Bioorg Med Chem; 2009 Jun; 17(11):3916-22. PubMed ID: 19419876
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The regulation of the interaction between F-actin and muscle fructose 1,6-bisphosphatase.
    Rakus D; Gizak A; Dzugaj A
    Int J Biol Macromol; 2005 Mar; 35(1-2):33-8. PubMed ID: 15769513
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biological evaluation and SAR analysis of novel covalent inhibitors against fructose-1,6-bisphosphatase.
    Han X; Huang Y; Wei L; Chen H; Guo Y; Tang Z; Hu W; Xia Q; Wang Q; Yan J; Ren Y
    Bioorg Med Chem; 2020 Sep; 28(18):115624. PubMed ID: 32828433
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rational design, synthesis, and potency of N-substituted indoles, pyrroles, and triarylpyrazoles as potential fructose 1,6-bisphosphatase inhibitors.
    Rudnitskaya A; Borkin DA; Huynh K; Török B; Stieglitz K
    ChemMedChem; 2010 Mar; 5(3):384-9. PubMed ID: 20069623
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Allosteric inhibition of fructose-1,6-bisphosphatase by anilinoquinazolines.
    Wright SW; Hageman DL; McClure LD; Carlo AA; Treadway JL; Mathiowetz AM; Withka JM; Bauer PH
    Bioorg Med Chem Lett; 2001 Jan; 11(1):17-21. PubMed ID: 11140724
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discovery of novel allosteric site and covalent inhibitors of FBPase with potent hypoglycemic effects.
    Huang Y; Wei L; Han X; Chen H; Ren Y; Xu Y; Song R; Rao L; Su C; Peng C; Feng L; Wan J
    Eur J Med Chem; 2019 Dec; 184():111749. PubMed ID: 31589992
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In silico screening of a novel scaffold for fructose-1,6-bisphosatase (FBPase) inhibitors.
    Huang Y; Chi B; Xu Y; Song R; Wei L; Rao L; Feng L; Ren Y; Wan J
    J Mol Graph Model; 2019 Jan; 86():142-148. PubMed ID: 30366190
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New insight into the binding modes of TNP-AMP to human liver fructose-1,6-bisphosphatase.
    Han X; Huang Y; Zhang R; Xiao S; Zhu S; Qin N; Hong Z; Wei L; Feng J; Ren Y; Feng L; Wan J
    Spectrochim Acta A Mol Biomol Spectrosc; 2016 Aug; 165():155-160. PubMed ID: 27137358
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fructose-1,6-bisphosphatase Inhibitors. 2. Design, synthesis, and structure-activity relationship of a series of phosphonic acid containing benzimidazoles that function as 5'-adenosinemonophosphate (AMP) mimics.
    Dang Q; Kasibhatla SR; Xiao W; Liu Y; Dare J; Taplin F; Reddy KR; Scarlato GR; Gibson T; van Poelje PD; Potter SC; Erion MD
    J Med Chem; 2010 Jan; 53(1):441-51. PubMed ID: 20055427
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Localization of chicken muscle FBPase in cardiomyocyte nuclei.
    Zmojdzian M; Dziewulska-Szwajkowska D; Dzugaj A
    Comp Biochem Physiol B Biochem Mol Biol; 2005 Jan; 140(1):37-43. PubMed ID: 15621507
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sulfonylureido thiazoles as fructose-1,6-bisphosphatase inhibitors for the treatment of type-2 diabetes.
    Kitas E; Mohr P; Kuhn B; Hebeisen P; Wessel HP; Haap W; Ruf A; Benz J; Joseph C; Huber W; Sanchez RA; Paehler A; Benardeau A; Gubler M; Schott B; Tozzo E
    Bioorg Med Chem Lett; 2010 Jan; 20(2):594-9. PubMed ID: 19969452
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advances in glycogen phosphorylase inhibitor design.
    Oikonomakos NG; Somsák L
    Curr Opin Investig Drugs; 2008 Apr; 9(4):379-95. PubMed ID: 18393105
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Designing inhibitors against fructose 1,6-bisphosphatase: exploring natural products for novel inhibitor scaffolds.
    Heng S; Harris KM; Kantrowitz ER
    Eur J Med Chem; 2010 Apr; 45(4):1478-84. PubMed ID: 20116906
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The origin of the high sensitivity of muscle fructose 1,6-bisphosphatase towards AMP.
    Rakus D; Maciaszczyk E; Wawrzycka D; Ułaszewski S; Eschrich K; Dzugaj A
    FEBS Lett; 2005 Oct; 579(25):5577-81. PubMed ID: 16213487
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Different sensitivities of mutants and chimeric forms of human muscle and liver fructose-1,6-bisphosphatases towards AMP.
    Rakus D; Tillmann H; Wysocki R; Ulaszewski S; Eschrich K; Dzugaj A
    Biol Chem; 2003 Jan; 384(1):51-8. PubMed ID: 12674499
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure-based drug design of tricyclic 8H-indeno[1,2-d][1,3]thiazoles as potent FBPase inhibitors.
    Tsukada T; Takahashi M; Takemoto T; Kanno O; Yamane T; Kawamura S; Nishi T
    Bioorg Med Chem Lett; 2010 Feb; 20(3):1004-7. PubMed ID: 20045638
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fructose-1,6-bisphosphatase inhibitors: A new valid approach for management of type 2 diabetes mellitus.
    Kaur R; Dahiya L; Kumar M
    Eur J Med Chem; 2017 Dec; 141():473-505. PubMed ID: 29055870
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anilinoquinazoline inhibitors of fructose 1,6-bisphosphatase bind at a novel allosteric site: synthesis, in vitro characterization, and X-ray crystallography.
    Wright SW; Carlo AA; Carty MD; Danley DE; Hageman DL; Karam GA; Levy CB; Mansour MN; Mathiowetz AM; McClure LD; Nestor NB; McPherson RK; Pandit J; Pustilnik LR; Schulte GK; Soeller WC; Treadway JL; Wang IK; Bauer PH
    J Med Chem; 2002 Aug; 45(18):3865-77. PubMed ID: 12190310
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.